6.32
-0.14(-2.17%)
Currency In USD
| Previous Close | 6.46 |
| Open | 6.34 |
| Day High | 6.45 |
| Day Low | 6.19 |
| 52-Week High | 15.1 |
| 52-Week Low | 4.02 |
| Volume | 639,657 |
| Average Volume | 1.34M |
| Market Cap | 343.04M |
| PE | -2.47 |
| EPS | -2.56 |
| Moving Average 50 Days | 5.36 |
| Moving Average 200 Days | 7.92 |
| Change | -0.14 |
If you invested $1000 in Emergent BioSolutions Inc. (EBS) 10 years ago, it would be worth $201.47 as of June 01, 2025 at a share price of $6.32. Whereas If you bought $1000 worth of Emergent BioSolutions Inc. (EBS) shares 5 years ago, it would be worth $70.78 as of June 01, 2025 at a share price of $6.32.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Emergent BioSolutions to Participate in Upcoming Investor Conferences
GlobeNewswire Inc.
May 14, 2025 11:32 AM GMT
GAITHERSBURG, Md., May 14, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of its executive management team will participate in the following investor conferences: RBC Global Healthcare Conference (New Y
Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health
GlobeNewswire Inc.
May 01, 2025 9:07 PM GMT
Agreement will facilitate widespread distribution of NARCAN® Nasal Spray throughout OntarioWINNIPEG, Manitoba, May 01, 2025 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced a maximum three-year agreement with a value of a
Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025
GlobeNewswire Inc.
Apr 22, 2025 12:00 PM GMT
GAITHERSBURG, Md., April 22, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, May 7, 2025, at 5:00 pm eastern time to discuss the financial results for the first quarter of 2025. Participants